The Quality Lowdown: Alvotech, Lupin, Cipla, Lilly, Rentschler Inspection Findings And Akorn Recall

US FDA finds flawed data integrity, investigations, aseptic practices and more at range of foreign and domestic drug product manufacturing facilities, while a bankruptcy leads to a massive drug recall.

The Quality Lowdown

Several inspection reports the US Food and Drug Administration has posted recently in redacted form provide insight into the kinds of quality issues that are challenging different types of drug manufacturers.

The main takeaway: the FDA is finding problems in manufacturing quality whether the site is new or old, whether it...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance